Liver transplant is the treatment of choice for selected benign and malignant conditions in the liver. In many patients with end-stage liver failure or cirrhosis, liver transplant offers the only chance of long-term survival and cure. Similarly, for selected patients with liver malignancies such as hepatocellular carcinoma or cholangiocarcinoma, liver transplant is the only treatment option which offers the best chance if not only option for cure. The department works closely with the Department of Gastroenterology and Hepatology and other departments within the SingHealth Transplant umbrella in managing patients before and after liver transplant,
The department's surgeons have a vast experience in performing liver transplant for benign and malignant conditions of the liver since the liver transplant program was started in 2005. It offers both deceased donor and living donor liver transplant and has experience with complex transplant procedures such as small for size graft and ABO-incompatible transplant. Presently, it performs over 20 liver transplants per annum.
Importantly, its post-transplant recipient outcomes (1-year and 5-year patient and graft survivals) are equivalent if not superior to international registries such as the UNOS database (USA). It also has not had a living liver donor mortality since its inception.